Heterogeneity in COVID‐19 Convalescent Plasma Clinical Trials
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2281
Abstract: Due to the outbreak of the coronavirus disease 2019 (COVID19) pandemic, clinical trial (CT) research for efficacy and safety evaluation of convalescent plasma (CP) accelerated globally. In trial planning and approval, clinical researcher and regulatory… read more here.
Keywords: convalescent; covid convalescent; convalescent plasma; heterogeneity covid ... See more keywords